Publication | Closed Access

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

Ten-year AnalysisBreast OncologyMedicineClinical OncologyBreast CancerCancer TreatmentTherapy Decision MakingOncologyRadiation OncologyCancer ResearchRadiologyHealth Sciences